Related Experiment Video
Updated: May 21, 2026
09:16
A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
Published on: January 22, 2016
CD200 attenuates methamphetamine-induced microglial activation and dopamine depletion
Xia Yue1, Dongfang Qiao1, Aifeng Wang1
1Department of Forensic Science, Southern Medical University, Guangzhou, 510515, China.
Summary
Cluster of differentiation molecule 200 (CD200) demonstrated neuroprotective effects against methamphetamine (METH) neurotoxicity. CD200 inhibited METH-induced microglial activation and reversed dopamine depletion in the striatum.
Area of Science:
- Neuroscience
- Immunology
- Pharmacology
Background:
- Methamphetamine (METH) abuse causes significant neurotoxicity, particularly affecting dopaminergic systems.
- Microglial activation plays a critical role in METH-induced neuroinflammation and neuronal damage.
- Cluster of differentiation molecule 200 (CD200) is a transmembrane protein involved in regulating immune responses and has shown potential in modulating neuroinflammation.
Purpose of the Study:
- To investigate the neuroprotective potential of CD200 against METH-induced neurotoxicity.
- To elucidate the mechanisms underlying CD200's effects, focusing on microglial activation and dopaminergic function.
Main Methods:
- In vitro studies utilized neuron-microglia cultures treated with METH and CD200-Fc to assess microglia activation (MHC-II/CD11b ratio) and cytokine secretion (IL-1β, TNF-α) via flow cytometry and ELISA.
- In vivo studies involved Sprague-Dawley rats administered METH and/or CD200-Fc, with striatal dopamine levels measured by HPLC and microglial activation assessed immunohistochemically (Iba-1).
Main Results:
- METH significantly increased microglia activation and elevated IL-1β and TNF-α secretion in vitro, effects attenuated by CD200-Fc.
- In vivo, METH induced striatal dopamine depletion and increased Iba-1 positive microglia, which were partially reversed and reduced, respectively, by CD200-Fc treatment.
- CD200-Fc treatment demonstrated a protective effect against METH-induced neurotoxicity in both experimental models.
Conclusions:
- CD200 exhibits significant neuroprotective properties against METH-induced neurotoxicity.
- CD200 exerts its neuroprotective effects primarily by inhibiting METH-induced microglial activation.
- CD200 may serve as a therapeutic target for mitigating METH-induced damage by preserving striatal dopamine levels.
Related Concept Videos
01:20Desensitization and Tachyphylaxis
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...
Several...
01:29Drugs Affecting Neurotransmitter Synthesis
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
01:27CNS Depressants: Alcohol and Nicotine
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
01:24CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its effects by...
01:25Adrenergic Agonists: Indirect-Acting Agents
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...